Submit Data |  Help |  Video Tutorials |  News |  Publications |  FTP Download |  REST API |  Citing RGD |  Contact   

Mutation in the transcriptional coactivator EYA4 causes dilated cardiomyopathy and sensorineural hearing loss.

Authors: Schonberger, J  Wang, L  Shin, JT  Kim, SD  Depreux, FF  Zhu, H  Zon, L  Pizard, A  Kim, JB  MacRae, CA  Mungall, AJ  Seidman, JG  Seidman, CE 
Citation: Schonberger J, etal., Nat Genet. 2005 Apr;37(4):418-22. Epub 2005 Feb 27.
Pubmed: (View Article at PubMed) PMID:15735644
DOI: Full-text: DOI:10.1038/ng1527

We identified a human mutation that causes dilated cardiomyopathy and heart failure preceded by sensorineural hearing loss (SNHL). Unlike previously described mutations causing dilated cardiomyopathy that affect structural proteins, this mutation deletes 4,846 bp of the human transcriptional coactivator gene EYA4. To elucidate the roles of eya4 in heart function, we studied zebrafish embryos injected with antisense morpholino oligonucleotides. Attenuated eya4 transcript levels produced morphologic and hemodynamic features of heart failure. To determine why previously described mutated EYA4 alleles cause SNHL without heart disease, we examined biochemical interactions of mutant Eya4 peptides. Eya4 peptides associated with SNHL, but not the shortened 193-amino acid peptide associated with dilated cardiomyopathy and SNHL, bound wild-type Eya4 and associated with Six proteins. These data define unrecognized and crucial roles for Eya4-Six-mediated transcriptional regulation in normal heart function.


Disease Annotations
Objects Annotated

Additional Information

CRRD Object Information
CRRD ID: 1598455
Created: 2006-11-29
Species: All species
Last Modified: 2006-11-29
Status: ACTIVE


RGD is funded by grant HL64541 from the National Heart, Lung, and Blood Institute on behalf of the NIH.